We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Stem Cells May Repair Injured Heart Muscle

By Biotechdaily staff writers
Posted on 20 May 2002
An animal study suggests that transplanting embryonic stem cells can help repair injured heart muscle and improve cardiac function following heart attacks and congestive heart failure (CHF). More...
The study was conducted by researchers at Beth Israel Deaconess Medical Center (BIDMC, Boston, MA, USA).

CHF is caused by the destruction of cardiomyocytes during a heart attack, resulting in ventricular dysfunction. The study was designed to determine whether implanted embryonic stem cells could survive in injured heart muscle and improve function. One of the advantages in using embryonic stem cells over other cells is to reduce immunoreactivity. The researchers surgically induced a heart attack in two groups of rats, one treated with a culture of embryonic stem mouse cells and one with a sham culture. Injections of stem cells were made at three separate sites in the heart, one on the place the attack took place and two in the heart muscle bordering the area.

Six weeks later, the researchers found that heart attack damage was reduced in the animals implanted with the stem cells. This group also showed significant improvement in left ventricular function. Animals in the control group did not show any improvement. Calculations revealed that the number of marked cells had successfully replicated, with 7.3% growth in the number of enzymatically isolated single cardiomyocytes. The cells were also rod-shaped with clear striations that mimicked heart muscle cells.

"These data strongly suggest that cardiogenesis, or growth of new cardiomyocytes, occurred in the damaged heart muscle following embryonic stem cell transplantation,” said Dr. Yong Fu Xiao, department of cardiology at BIDMC.




Related Links:
Beth Israel Medical Center

New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
New
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more

Pathology

view channel
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.